Toronto, Ontario — SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed its previously announced public offering (the “Offering”). Pursuant to the Offering, SQI issued 8,400,000 units of the Company (“Units”) […]
Hawthorne, CA and Rutherford, NJ — Cancer Genetics, Inc. (Nasdaq: CGIX) and BioDiscovery, Inc. have announced expansion of the Nexus Copy Number Discovery platform in CGI research to uncover novel biomarkers which are predictive of cancer outcomes. “Cancer Genetics has been able to leverage the Nexus Copy Number platform’s unique ability to quickly digest large […]
Hawthorne, CA and Lexington, MA – BioDiscovery, Inc., a leader in DNA structural variant analysis laboratory software for copy number (CNV) and sequence variation, and N-of-One, the leading provider of molecular interpretation and therapeutic strategies for precision medicine in oncology, today announced a partnership to jointly provide integrated genomic analysis interpretation solutions. This partnership will […]
CONCORD, Calif.– Cerus Corporation (NASDAQ: CERS) announced today that Dr. Frank Witney, president and chief executive officer of Affymetrix, has joined its board of directors and the compensation committee. Dr. Witney joins the board with over 30 years of experience in the life science industry, specifically focused on corporate strategy and commercialization of products in […]
Toronto, Ontario — SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has expanded its previously announced product development relationship with a global pharmaceutical company (“Global Pharma 1”) to develop a custom multiplex test to support the […]
Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its range of research-validated CytoSure Molecular Arrays to investigate DNA copy number variation (CNV) underlying a variety of genetic disorders. Designed and optimised in collaboration with experts at Emory Genetics Laboratory (EGL; Atlanta, USA), the arrays are the ideal complement to DNA sequencing, providing a […]
Bozeman, MT -— Today Golden Helix released Version 8 of its genomic analysis software, SNP & Variation Suite (SVS), designed to empower researchers conducting complex genetic research. SVS is used by hundreds of scientists, doctors, and bioinformaticians around the world to unravel the genetic cause of disease and other phenotypes. Version 8 introduces the integration […]
Oxford Gene Technology (OGT), a provider of innovative genetics research solutions, today announced the acquisition of Cambridge-based Cytocell Limited (Cytocell), a leading provider of DNA technology for the detection of gene rearrangements related to inherited genetic disease and cancer. Key benefits of the acquisition are summarised below: ?Expansion of OGT’s genomic medicine offering. Cytocell’s portfolio […]
Munich-based nanotechnology specialist attocube took over the majority share in Neaspec GmbH by mid-February. Neaspec and attocube share a common history and the same values: They have been founded as spin-offs from prestigious research institutes (CeNS & Max-Planck-Institute), are passionate in developing excellent products, enabling applications close to the limit of what is physically and […]
TSI, a global leader in precision instrumentation, today announced that it has acquired the business assets and Raman Spectroscopy Technology from Enwave Optronics, Inc. (Irvine, CA). “We are excited to welcome the Enwave team to TSI and to incorporate the company’s portfolio of high precision instruments to TSI’s current chemical analysis business. Raman technology expands […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
